Savior LLC’s Relay Therapeutics RLAY Stock Holding History

Savior LLC’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-40	Closed	-$1K	–	632
2021 Q2	$1K	Hold	40	–	–	﹤0.01%	819
2021 Q1	$1K	Buy	40 +20	+100%	+$868	﹤0.01%	837
2020 Q4	$1K	Buy	+20	New	+$904	﹤0.01%	809

Other funds holding RLAY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Savior LLC's RLAY Position: Q3 2021 in Review

Savior LLC sold out of Relay Therapeutics (RLAY) in Q3 2021, closing a stake of 40 shares — an estimated $1K sold.

Savior LLC first reported a position in RLAY in Q4 2020 and held it in 3 quarters. The position peaked at $1K in Q2 2021. 132 funds tracked by Wall St. Rank hold RLAY as of Q3 2021.

Savior LLC reported no remaining Relay Therapeutics position as of Q3 2021 after selling out during the quarter.
Savior LLC sold 40 Relay Therapeutics shares in Q3 2021, an estimated $1K.
Savior LLC first reported a position in Relay Therapeutics in Q4 2020 and held it in 3 quarters.
Savior LLC's Relay Therapeutics position peaked at $1K in Q2 2021.
132 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.